Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
Resource Type
Article
Authors
Sartore-Bianchi, Andrea ; Trusolino, Livio ; Martino, Cosimo ; Bencardino, Katia ; Lonardi, Sara ; Bergamo, Francesca ; Zagonel, Vittorina ; Leone, Francesco ; Depetris, Ilaria ; Martinelli, Erika ; Troiani, Teresa ; Ciardiello, Fortunato ; Racca, Patrizia ; Bertotti, Andrea ; Siravegna, Giulia ; Torri, Valter ; Amatu, Alessio ; Ghezzi, Silvia ; Marrapese, Giovanna ; Palmeri, Laura ; Valtorta, Emanuele ; Cassingena, Andrea ; Lauricella, Calogero ; Vanzulli, Angelo ; Regge, Daniele ; Veronese, Silvio ; Comoglio, Paolo M ; Bardelli, Alberto ; Marsoni, Silvia ; Siena, Salvatore
Source
In The Lancet Oncology June 2016 17(6):738-746
Subject
Primary Research Articles
Language
ISSN
1470-2045